Lung cancer is the most widely diagnosed malignancy in the world. Understanding early-stage disease will give insight into its pathogenesis. Despite the fact that preinvasive lesions are challenging to isolate, and often yield insufficient DNA for the analysis of multiple loci, genomic profiling of such lesions will lead to the discovery of causal genetic alterations, which may be otherwise masked by the gross instability associated with tumors. In this study, we report the identification of multiple early genetic events on chromosome 5p in lung cancer progression. Using a highresolution 5p-specific genomic array, which contains a tiling path of DNA segments for comparative genomic hybridization, nine novel minimal regions of loss and gain were discovered in bronchial carcinoma in situ (CIS) specimens. Within these regions we identified two candidate genes novel to lung cancer. The 0.27 Mbp region at 5p15.2 contains a single gene, Triple Functional Domain, which we determined to be differentially expressed in tumors. The 0.34 Mbp region at 5p13.2 contains Glial Cell Line-Derived Neurotrophic Factor (GDNF), which is a ligand for the RET oncogene product and is normally expressed during lung development (but absent in adult lung tissue). Our data showed not only that GDNF is overexpressed at the transcript level in squamous non-small-cell lung carcinoma, but also that the GDNF protein is present in early-stage lesions. Reactivation of the fetal lung expressed GDNF in early lesions and its amplification in CIS suggests an early role in tumorigenesis. These results highlight the value of examining the genomes of pre-invasive stages of cancer at tiling resolution.
Introduction
Lung cancer is the most commonly diagnosed cancer worldwide, with over 170 000 new cases diagnosed last year in the United States alone (Jemal et al., 2003) . The vast majority of cases are caused by smoking tobacco, with non-small-cell lung cancer (NSCLC) accounting for approximately 80% of cases (Travis et al., 1999) . Squamous cell carcinoma (SqCC), the squamous subtype of NSCLC, progresses through histopathological stages from various degrees of hyperplasia and dysplasia, to carcinoma in situ (CIS), to invasive carcinoma, and finally to metastasis Osada and Takahashi, 2002; Garnis et al., 2004a) . Allelotype analysis of NSCLC and cell line derivatives has yielded much insight into genetic alterations in lung cancer and gene expression profiling studies have contributed to disease subclassification. However, there are few reports on early-stage lesions, mainly due to the difficulty in obtaining such specimens. Studies of chromosome arm 3p, among others, have provided evidence that cumulative molecular alterations do accompany the progressive morphological changes that occur during the multi-stage development of lung SqCC (Wistuba et al., 2000; Minna et al., 2002; Zabarovsky et al., 2002) .
While genetic alterations in tumors are common, examination of tissues earlier in tumorigenesis is more likely to identify causal events leading to tumor progression. These important early alterations may be masked by the complex pattern of genetic alterations often associated with genetic instability in the later stages of disease. Molecular cytogenetic studies have shown that chromosomal aberrations occur on the short arm of chromosome 5 (5p) in all major lung tumor types (Ried et al., 1994; Balsara et al., 1997; Ullmann et al., 1998; Luk et al., 2001) . We have recently developed a 5p-specific bacterial artificial chromosome (BAC) genomic array for use in array comparative genomic hybridization (CGH) analysis. This array comprehensively covers 5p in 491 overlapping segments, allowing for high-resolution detection of copy number alterations (Coe et al., 2005) . The ability to profile the entire 5p chromosome arm in one experiment -as compared to traditional marker-based techniques -is key to the analysis of minute pre-invasive CIS lesions due to the fact that these lesions are small and require microdissection which yields limited DNA.
In this study, we analysed bronchial CIS lesions and SqCC tumors through the use of a unique 5p-specific BAC array. Alignment of array CGH profiles revealed multiple distinct regions of amplification and deletion in CIS that would otherwise appear to be masked in the later-stage tumor samples. The identification of these recurrent alterations not only led to the discovery of candidate genes but also highlights the importance of studying the genomics of early-stage lung cancer.
Results and discussion
5p array CGH analysis of lung CIS and tumors 5p aberrations have been shown to be frequent in NSCLC. To investigate the role of 5p in the progression of CIS (pre-invasive) to tumors (invasive), we compared eight microdissected bronchial CIS lesions and nine SqCC tumor samples for genetic alterations using a chromosome arm-specific array containing 491 overlapping BAC clones that spans 5p from centromere (p11) to telomere (p15.33) (Coe et al., 2005) . Signal intensity ratios for each triplicate-spotted BAC (giving a total of >25 000 data points across all 17 samples) were calculated and displayed as log2 plots using SeeGH software (Chi et al., 2004) . Figure 1a gives examples of 5p SeeGH karyograms illustrating a profile with minimal copy number changes (T5850), a profile with whole arm amplification (T11773), and profiles with multiple segmental gains and losses (T10999, T8611). Alterations were detected in nearly all of the samples analysed: in seven of the eight CIS samples and all of the tumors. Figure 1b shows the alignment of all 17 profiles, displayed in Java TreeView with colorimetric representation. Four tumors and one CIS (T11278, T3010, T8611, T11773, C125) showed amplifications spanning nearly the entire chromosome arm (Figure 1b) . Notably, smaller and more distinct regions of gain and loss were apparent in the CIS profiles, for example, the amplified regions A3 and A4 within 5p15.2. Furthermore, recurrent deletions were prominent in CIS but undetected in tumors, suggesting the possibility that deletions could be masked in tumors by later genetic events (Figure 1b) .
Our data revealed broader alterations in tumors relative to those seen in CIS samples. Array CGH profile alignment enabled identification of six recurrent regions of amplification amongst the tumor and CIS samples (A1-A6) and three recurring regions of deletion within the CIS samples (D1-D3) ( Figure 1b , Table 1 ). Due to the comprehensive nature of the 5p array, we observed submegabase changes which account for seven of the nine recurrent regions of alteration. These small alterations would likely have escaped detection through the use of traditional marker-based techniques.
Novel amplifications defined in CIS lesions
To establish a threshold, normal male DNA versus normal male DNA hybridizations were used to determine the background experimental noise at three standard deviations (Garnis et al., 2003) . This placed our threshold at a 70.13 log2 raw ratio, which was used to define regions of genetic alteration. In addition, for a region to be defined as altered, it had to involve consecutive overlapping BAC clones. To increase the likelihood of identifying causal genetic events, we applied stringent selection criteria requiring the presence of alterations in at least half of the CIS samples to define a recurrent region. Strikingly, of the six recurrent amplified regions defined, five (Regions A2-A6) have not been previously reported in SqCC. The previously reported amplification at 5p15 (Bryce et al., 2000; Saretzki et al., 2002) , which contains the well-characterized Human Telomerase Reverse Transcriptase gene (hTERT), falls within Region A1. However, the other locus known to be amplified in tumors (5p13.2), containing S-phase kinase-associated protein 2 (Skp2), although detected in the array CGH tumor profiles, did not qualify as a region of interest in our study due to the absence of amplification in the CIS samples at this locus (Zhu et al., 2004) . Remarkably, with the exception of Region A1, all other amplifications were o1 megabasepair (Mbp) in size (Table 1) . Regions A2, A3, A4, and A6 contain only a single annotated gene, while A5 contains only two known genes. The boundaries of these narrow regions are listed in Table 1 . Of the four genes in single gene regions, Catenin Delta-2 (CTNND2) has been shown to be overexpressed in prostate cancer (Burger et al., 2002) and Steroid 5-Alpha-Reductase (SRD5A1), which catalyses the conversion of testosterone into the more potent androgen dihydrotestosterone (Harris et al., 1992) , has been shown to be overexpressed in breast cancer (Wiebe and Lewis, 2003) . The Triple Functional Domain gene (TRIO) in Region A4 ( Figure 1c ) and the Glial Cell Line-Derived Neurotrophic Factor gene (GDNF) in Region A6 (Figure 1d ), however, have not been directly implicated in cancer and were further investigated in this study (see below).
Novel deletions defined by CIS lesions
Previous chromosomal CGH studies have identified 5p amplification as a common event in NSCLC; however, copy number reduction is rarely described. Studies using microsatellite markers have revealed loss of heterozygosity (LOH) at the centromeric end of 5p (Wieland and Bohm, 1994; Wieland et al., 1996) . Our analysis of the tumor profiles is consistent with previous reports in that we did not detect recurrent regions of deletion in tumor samples. To our knowledge, specific recurrent regions of deletion have not been defined within 5p in NSCLC. However, when we aligned the eight CIS profiles, three distinct recurrent regions of deletion emerged (Figure 1b) . Recurrent deletions were defined by their presence in at least four of the eight samples. Two of the three regions were o1 Mbp in size (Table 1 ). The 1.1 Mbp Region D1 contains only one known geneCadherin 12 (CDH12) -while no genes have been annotated within Regions D2 and D3. These observations reinforce the value in analysing pre-invasive disease, as it has led to the identification of a small deletion that contains a single gene candidate.
Genomic and gene expression analysis of TRIO We have identified seven candidate genes that fall within small regions containing only one or two genes (Table 1) . Since a detailed analysis of all the candidate genes is beyond the scope of this study, we focused on two genes: TRIO and GDNF. Figure 2a shows a close-up image of SeeGH karyograms for the four CIS profiles that are amplified at the TRIO locus. CIS samples (C59, C127, and C60) show discrete amplification at this region, whereas C125 shows a larger amplification that extends from BAC RP11-20B15 to the centromere. Amplification of the TRIO region is maintained in tumors ( Figure 1c) . Next, we investigated TRIO for differential expression by realtime PCR in eight paired normal and SqCC samples. We observed overexpression of TRIO in six of the eight pairs (Po0.05) (Figure 2b ). This expression pattern is confirmed in an additional panel of 13 paired normal ) and the UCSC genome browser (Kent et al., 2002) were used to facilitate the selection of a clone subset from the whole genome BAC re-array set (Krzywinski et al., 2004) . This represents minimal overlapping coverage of the short arm of chromosome 5. We have made this clone list publicly available at http://www.bccrc.ca/cg/ArrayCGH_Group.html. Linker-mediated PCR (LM-PCR) of BAC DNA samples was performed to obtain sufficient concentration for spotting (Watson et al., 2004) . This subset consists of 491 fingerprint-verified BAC clones spanning the B50 Mbp arm of chromosome 5 from 5p11 to 5p15.33. In addition to the 5p clones, 96 random loci scattered throughout the human genome were included on the array as internal controls. LM-PCR amplified human genomic DNA spots were also added to the array in order to facilitate normalization of our signal intensities as described previously (Garnis et al., 2003; Coe et al., 2005) . Array CGH profiling was performed by co-hybridizing 100 ng of reference and sample DNA labeled with cyanine 5 and cyanine 3 dCTPs, respectively. The labeling, hybridization, and imaging protocols are described previously (Garnis et al., 2003) . Arrays were prehybridized at 421C with DIG Easy hybridization solution (Roche, Mississauga, ON, USA) containing 1% BSA and 2 mg/ml sheared herring sperm DNA. Denatured probes in hybridization buffer containing 6 mg/ml yeast tRNA were applied to the array and hybridized at 421C for 36 h. Arrays were washed repeatedly with 0.1 Â SSC/0.1% SDS at room temperature. Hybridized arrays were imaged using a CCD-based imaging system and analyzed using the SoftWorx array analysis program (ArrayWorx eAuto, API, Issaquah, WA, USA). Normalization was performed as described previously (Garnis et al., 2003 (Garnis et al., , 2004b . Normalized log2 signal intensity ratios were plotted using SeeGH software, version 1.7 (Chi et al., 2004) . A log2 signal ratio of zero represents equivalent copy number between the sample and the reference DNA. Clones with standard deviations among the triplicate spots >0.075 or a signal-to-noise ratio >20 were disqualified from further analysis. (a) 5p array CGH profiles showing normal copy number (T5850), whole arm amplification (T11773), and multiple segmental copy number changes (T10999, T8611). 5p cytoband pattern is to the left. Vertical lines denote log2 signal ratios from À1 to 1 with copy number increases to the right (red lines) and decreases to the left (green lines) of zero (purple line). Each black dot represents a single BAC clone. (b) Colorimetric representation of 5p array CGH data viewed by Java TreeView. To compare multiple profiles, we used Java TreeView version 1.0.3 to generate a colored gene copy number matrix (http://jtreeview.sourceforge.net). Intensities of red and green coloration indicate an increased or decreased log2 signal ratio for each clone, respectively. Gray coloration indicates clones discarded due to high standard deviations (>0.075) or signalto-noise ratios. Each column represents a separate array CGH profile. Each row corresponds to a BAC clone and each column represents a CIS or tumor sample (sample ID at top). 5p cytoband pattern is to the left. (Figure 2c, d) . The concordance of copy number increase with overexpression in tumor samples implicates a role for TRIO in lung SqCC, while its frequent amplification in pre-invasive lesions suggests its early involvement in tumorigenesis. The TRIO protein contains three functional domains: a serine/ threonine kinase domain and two guanine nucleotide exchange factor domains for the family of Rho-like GTPases, specific for Rac1 and RhoA, respectively. These functional domains suggest that this enzyme may play a key role in several signaling pathways that control cell proliferation (Debant et al., 1996) . Recent reports have implicated TRIO in tumorigenesis (Zheng et al., 2004; Coe et al., 2005) . Amplification and overexpression of GDNF in pre-invasive lesions Similar to TRIO, the GDNF region is amplified in CIS samples as well as in tumor samples (Figure 1d ). In Figure 3a the amplified region containing GDNF is highlighted in five CIS profiles. Real-time PCR analysis showed striking overexpression of GDNF in five of the eight paired normal and tumor RNA samples (Po0.05) (Figure 3b ). The absence of GDNF expression in normal adult lung tissue agrees with a previous observation that GDNF is expressed in fetal but absent in post-natal lung tissue (Fromont-Hankard et al., 2002) . GDNF expression in tumors suggests its potential involvement in tumorigenesis.
To further evaluate the tumor-specific expression of GDNF at the protein level, immunohistochemical analysis was performed. A monoclonal antibody specific for GDNF showed conspicuous membrane staining with less intense cytoplasmic staining (Figure 3c ). Staining was not detected in normal bronchial epithelium. We further analysed a panel of samples which included hyperplasia, CIS, and tumor samples. Immunostaining was not evident in hyperplasia but was detected in CIS samples and invasive tumors. These data suggest expression of GDNF in early histological lung cancer stages. This is further supported by the fact GDNF is the ligand for the RET proto-oncogene, which is known to transduce signals for cell growth and differentiation (Takahashi, 2001 ).
Discussion
The identification of early-stage genetic events that drive the progression of squamous cell lung cancer requires the study of pre-invasive lesions. Our data suggest the possibility that early causal events in tumorigenesis may be masked by later-stage genomic instability. The ability of the CIS profiles to narrow our focus within the tumor profiles demonstrates the importance of studying early- Amplified region containing GDNF is highlighted. (b) Real-time PCR expression analysis of GDNF in eight matched normal (gray) and tumor (black) samples. For real-time PCR analysis, mRNA expression levels were quantitatively assessed by reverse transcription-PCR using the ABI PRISM 7700 Sequence Detection System, as described previously (Wang et al., 2002) . To avoid amplification of contaminating genomic DNA sequences, primers were designed to span two adjacent exons (CACTGACTTGGGTCTGGGCTAT and GTCTCAGCTGCATCGCAAG). All assays were carried out using duplicate samples of each RT product. The sample-to-sample variation of RNA/cDNA quantity was normalized using the 18S ribosomal RNA as the reference gene (Wang et al., 2002) . (c) Immunostaining of squamous cell lung tumor tissue sections with anti-GDNF monoclonal antibody (Santa Cruz Biotech) stage disease. In the past, such studies have been limited by the rarity and minute size of early-stage specimens. The development of the 5p genomic array has facilitated comprehensive analysis of the 5p chromosome arm for these precious samples. Consequently, we have identified nine distinct regions of alteration across 5p, of which eight are novel and seven are submegabase in size. These small alterations would likely have escaped detection through the use of limited resolution conventional marker-based techniques. This study has shown that the analysis of CIS samples with a comprehensive tiling path array is arguably one of the most effective ways to focus attention on those regions of the chromosome arm that contain genes potentially critical to disease progression.
We have assayed the expression levels of two of the candidate genes that fall within amplified regions, TRIO and GDNF, and found that both are significantly overexpressed in a panel of tumors compared with their matched normal RNA samples. More significantly, immunohistochemical analysis of GDNF, a ligand for RET, not only showed tumor-specific staining but was also present in pre-invasive stage specimens. Interestingly, GDNF expression is normally restricted to the fetal lung and is involved in lung development (Fromont-Hankard et al., 2002) . Our findings suggest that reactivation of this developmental gene may contribute to lung tumorigenesis at an early stage.
Materials and methods

Sample procurement
Formalin-fixed paraffin-embedded lung CIS samples used in array CGH analysis were collected by fluorescent bronchoscopy as part of the Lung Health Study at the British Columbia Cancer Agency (Lam et al., 2000; McWilliams et al., 2002) . Both fixed and frozen tissues were obtained from the archive of St Paul's Hospital, Vancouver and the Ontario Cancer Institute, Toronto. Hematoxylin and eosin-stained sections for each sample were graded and microdissected under the guidance of a lung pathologist. DNA extraction was previously described (Siwoski et al., 2002) and RNA was isolated using Trizol reagents (Invitrogen, Burlington, ON, USA). Samples were collected following approval by the Research Ethics Boards of the respective institutions.
Array CGHs
The establishment of the tiling set of clones spanning 5p and genomic array construction is described in Figure 1 legend. Array hybridizations were performed as described previously (Garnis et al., 2003 (Garnis et al., , 2004b . To compare multiple profiles, we used Java TreeView version 1.0.3 to generate a colored gene copy number matrix (http://jtreeview.sourceforge.net).
Gene expression analysis
RNA for reverse-transcriptase PCR was extracted from frozen tissue sections using Trizol reagent (Invitrogen, Burlington, ON, USA). cDNA was synthesized using the Superscript II RNAse H reverse-transcriptase system (Invitrogen). For semiquantitative RT-PCR, expression levels were determined by gene-specific PCR. PCR cycle conditions were as follows: one cycle of 951C, 1 min; 30-35 cycles of (951C, 30 s; 551C for b-actin and 601C for TRIO for 30 s; 721C, 1 min) and a 10 min extension at 721C. PCR products were resolved by polyacrylamide gel electrophoresis, imaged by SYBR green staining (Roche, Laval, Que, Canada) on a Molecular Dynamics Storm Phosphoimager model 860, and quantified using ImageQuant software (Molecular Dynamics, Piscataway, NJ, USA). The genes assayed were hypothesized to be overexpressed since they reside in amplicons. Therefore, a one-tailed Wilcoxon matched pairs signed ranks test was used to determine if overexpression of these genes was significant in sets of matched tumor and normal lung samples.
